Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program.
Kerr M, Tarabichi Y, Evans A, Mapel D, Pace W, Carter V, Couper A, Drummond MB, Feigler N, Federman A, Gandhi H, Hanania NA, Kaplan A, Kostikas K, Kruszyk M, van Melle M, Müllerová H, Murray R, Ohar J, Pollack M, Pullen R, Williams D, Wisnivesky J, Han MK, Meldrum C, Price D. Kerr M, et al. Among authors: mullerova h. Lancet Reg Health Am. 2023 Jul 28;24:100546. doi: 10.1016/j.lana.2023.100546. eCollection 2023 Aug. Lancet Reg Health Am. 2023. PMID: 37545746 Free PMC article.
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.
Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agustí A, Beasley R, Fageras M, Alacqua M, Papi A, Müllerová H, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Hughes R, et al. Among authors: mullerova h. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2803-2811. doi: 10.1016/j.jaip.2023.05.013. Epub 2023 May 23. J Allergy Clin Immunol Pract. 2023. PMID: 37230383 Free article.
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Stolz D, Hermansson E, Ouwens M, Singh B, Sharma A, Jackson D, Darken P, Marshall J, Bowen K, Müllerová H, Alcázar Navarrete B, Russell R, Han MK, Tansey-Dwyer D. Stolz D, et al. Among authors: mullerova h. Curr Med Res Opin. 2023 Oct;39(10):1395-1405. doi: 10.1080/03007995.2023.2247969. Epub 2023 Aug 29. Curr Med Res Opin. 2023. PMID: 37583267
The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort.
Agustí A, Hughes R, Rapsomaki E, Make B, Del Olmo R, Papi A, Price D, Benton L, Franzen S, Vestbo J, Mullerova H. Agustí A, et al. Among authors: mullerova h. ERJ Open Res. 2024 Feb 12;10(1):00895-2023. doi: 10.1183/23120541.00895-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38348246 Free PMC article.
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Tomaszewski EL, et al. Among authors: mullerova h. Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6. Respir Res. 2023. PMID: 37031164 Free PMC article.
Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy.
Marshall H, Wild JM, Smith LJ, Hardaker L, Fihn-Wikander T, Müllerová H, Hughes R. Marshall H, et al. Among authors: mullerova h. ERJ Open Res. 2023 Apr 3;9(2):00344-2022. doi: 10.1183/23120541.00344-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37020837 Free PMC article.
105 results